Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Quest Diagnostics
(NY:
DGX
)
135.69
+0.27 (+0.20%)
Streaming Delayed Price
Updated: 10:59 AM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
80,829
Open
135.00
Bid (Size)
135.60 (4)
Ask (Size)
135.76 (2)
Prev. Close
135.42
Today's Range
134.88 - 135.99
52wk Range
119.59 - 147.97
Shares Outstanding
122,180,759
Dividend Yield
2.09%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth
April 25, 2024
Intelligent Bio Solutions (Nasdaq: INBS) is a medical technology company developing and commercializing innovative, intelligent, rapid, noninvasive testing solutions.
Via
Talk Markets
Peering Into Quest Diagnostics's Recent Short Interest
April 24, 2024
Via
Benzinga
Performance
YTD
-3.64%
-3.64%
1 Month
+5.29%
+5.29%
3 Month
+4.26%
+4.26%
6 Month
+3.37%
+3.37%
1 Year
-7.59%
-7.59%
More News
Read More
The Analyst Landscape: 5 Takes On Quest Diagnostics
April 24, 2024
Via
Benzinga
Quest Diagnostics Says Sales In Q1 Increased For The First Time Since The Height Of Pandemic
April 23, 2024
Via
Benzinga
DGX Stock Earnings: Quest Diagnostics Beats EPS, Beats Revenue for Q1 2024
April 23, 2024
Via
InvestorPlace
US Stocks Set To Open Fresh Week Higher On Big Tech Earnings Hopes: Analyst Warns Any Letdown Could Push Market 'Deeper Into Oversold Territory'
April 22, 2024
Via
Benzinga
Balancing Dividends and Fundamentals: The Case of NYSE:DGX.
April 10, 2024
Via
Chartmill
Earnings Scheduled For April 23, 2024
April 23, 2024
Via
Benzinga
Key Takeaways From Quest Diagnostics Analyst Ratings
March 20, 2024
Via
Benzinga
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
April 21, 2024
Via
Benzinga
Why NYSE:DGX provides a good dividend, while having solid fundamentals.
March 19, 2024
Via
Chartmill
LifeMD Shares Come Back to Life on GLP-1 Business Growth
March 19, 2024
Via
MarketBeat
AMC Entertainment Tops The List Of High-Yielding Corporate Bonds — A Look At Yields As Bond Appetites Grow
March 18, 2024
Via
Benzinga
Topics
Bonds
Exposures
Debt Markets
(DGX) - Analyzing Quest Diagnostics's Short Interest
March 05, 2024
Via
Benzinga
Why NYSE:DGX provides a good dividend, while having solid fundamentals.
February 27, 2024
Via
Chartmill
Breaking Down Quest Diagnostics: 7 Analysts Share Their Views
February 26, 2024
Via
Benzinga
Is NYSE:DGX suited for dividend investing?
February 05, 2024
Via
Chartmill
Beyond The Numbers: 7 Analysts Discuss Quest Diagnostics Stock
February 02, 2024
Via
Benzinga
Spotify To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Wednesday
February 07, 2024
Via
Benzinga
Investor Sentiment Falls Sharply Following Fed's Rate Decision; Dow Dips Over 300 Points
February 01, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Quest Diagnostics Likely To Report Higher Q4 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
February 01, 2024
Via
Benzinga
The Top 3 Stocks in the High-Potential ‘Cancer Testing’ Market
January 18, 2024
Via
InvestorPlace
Earnings Scheduled For February 1, 2024
February 01, 2024
Via
Benzinga
Earnings Outlook For Quest Diagnostics
January 31, 2024
Via
Benzinga
Evolving Landscape For Alzheimer's Blood Tests Gains Momentum Amid Inaccuracy Concerns
January 12, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.